1. Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018;15:965–82.
2. Herbst RS, Heymach J V, Lippman SM. Molecular origins of cancer lung cancer. N Engl J Med. Massachusetts Medical Society; 2008;359:1367–80.
3. Cooper WA, Lam DCL, O’Toole SA, Minna JD. Molecular biology of lung cancer. J Thorac Dis. 2013;5(Suppl 5):S479–90.
4. Pendharkar D, Ausekar BV, Gupta S. Molecular biology of lung cancer-a review. Indian J Surg Oncol. 2013;4:120–4.
5. Hsu PP, Shaw AT. Lung cancer: a wiley genetic opponent. Cell. Elsevier Inc.; 2017;169:777–9.